Analysis of exhaled leukotrienes in nonasthmatic adult patients with seasonal allergic rhinitis
- 11 January 2005
- Vol. 60 (2) , 171-176
- https://doi.org/10.1111/j.1398-9995.2005.00675.x
Abstract
Background: Leukotrienes (LTs) are increased in exhaled breath condensate (EBC) in patients with asthma. So far no data have been reported about LT levels in nonasthmatic patients with seasonal allergic rhinitis (SAR). The aim of the study was to find out whether the LT levels in EBC were increased in the nonasthmatic adult patients with SAR both during and after the pollen season in comparison with healthy controls and to assess the changes of the LT levels after the pollen season.Methods: Twenty‐nine nonasthmatic adult patients with SAR underwent measurement of exhaled LTs in the EBC during and after the pollen season. Leukotrienes B4, C4, D4 and E4 were analysed by a specific and sensitive gas chromatography/mass spectrometry (GC/MS) assay and compared with 50 healthy nonsmoking controls. Spirometry, skin prick tests and nonspecific IgE were evaluated.Results: Leukotrienes concentrations (B4, E4 but not D4) were significantly increased in and after the pollen season in patients with SAR in comparison with healthy controls. In most of the samples, LT C4 was undetectable. The values of all exhaled LTs were significantly decreased after the pollen season compared with the seasonal baseline: LTB4 (P = 0.023), LTD4 (P = 0.020), LTE4 (P = 0.047).Conclusions: Levels of exhaled LTB4 and LTE4 were higher in SAR patients than in healthy controls and decreased after the pollen season as compared with levels in season. The SAR patients with the highest in season LT levels had also the post‐season levels elevated and this may be an early marker of inflammatory process in the lower airways despite the absence of clinical symptoms of asthma.Keywords
This publication has 24 references indexed in Scilit:
- Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2003
- Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastineAllergy, 2002
- Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fallAnnals of Allergy, Asthma & Immunology, 2002
- Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: Influence of natural allergen exposureJournal of Allergy and Clinical Immunology, 2000
- Measurement of Leukotrienes in HumansAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Leukotriene EM4 plasma levels in adult asthmatic patients with variable disease severityAllergy, 1997
- The effect of cetirizine on sulfidoleukotriene production by blood leukocytes in children with allergic rhinitisAllergy, 1995
- Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthmaJournal of Allergy and Clinical Immunology, 1995
- Antiallergic activity of loratadine: inhibition of leukotriene C4 release from human leucocytesClinical and Experimental Allergy, 1995
- Leukotrienes, LTC and LTB, in bronchoalveolar lavage in bronchial asthma and other respiratory diseasesJournal of Allergy and Clinical Immunology, 1989